Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials.
Journal
Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
pubmed:
6
4
2019
medline:
1
7
2020
entrez:
6
4
2019
Statut:
ppublish
Résumé
: We aimed to combine evidence from all heart failure trials that have investigated the effects of drugs with blood pressure (BP)-lowering properties to assess the extent to which such drugs reduce BP in heart failure, the association between the net change in BP between treatment arms and cause-specific outcomes and whether treatment effects (efficacy and safety) vary according to baseline BP. We conducted a systematic review and meta-analysis including randomized clinical trials of drugs with BP-lowering properties in patients with chronic heart failure with at least 300 patient-years follow-up. We included a total of 37 trials (91 950 patients) and showed that treatment with drugs with BP-lowering properties resulted in a small but significant decrease in SBP in patients with heart failure with no evidence that the efficacy and safety of those drugs varied according to baseline BP.
Identifiants
pubmed: 30950980
doi: 10.1097/HJH.0000000000002094
doi:
Substances chimiques
Cardiovascular Agents
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1757-1767Subventions
Organisme : Department of Health
ID : CDF-2015-08-074
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/19/64/34673
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/18/65/33872
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn